{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T04:02:07Z","timestamp":1748491327957,"version":"3.41.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,27]]},"DOI":"10.7759\/cureus.84937","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T06:26:22Z","timestamp":1748413582000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Treatment of Refractory Mucocutaneous Beh\u00e7et's Disease With Gastrointestinal Involvement Using Anti-tumor Necrosis Factor-Alpha (Anti-TNF-\u03b1) Therapy"],"prefix":"10.7759","author":[{"given":"Manar","family":"Elfatih Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghad","family":"Mazin Al-Issa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Emad Al-Zaidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal","family":"Elbadawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2012.53.1.35","article-title":"New insights in the clinical understanding of Beh\u00e7et's disease","volume":"53","author":"Cho SB","year":"2012","unstructured":"Cho SB, Cho S, Bang D. New insights in the clinical understanding of Beh\u00e7et's disease. Yonsei Med J. 2012, 53:35-42. 10.3349\/ymj.2012.53.1.35","journal-title":"Yonsei Med J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.12.006","article-title":"Beh\u00e7et's disease: new insights into pathophysiology, clinical features and treatment options","volume":"17","author":"Greco A","year":"2018","unstructured":"Greco A, De Virgilio A, Ralli M, et al.. Beh\u00e7et's disease: new insights into pathophysiology, clinical features and treatment options. Autoimmun Rev. 2018, 17:567-75. 10.1016\/j.autrev.2017.12.006","journal-title":"Autoimmun Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213567","article-title":"2018 update of the EULAR recommendations for the management of Beh\u00e7et's syndrome","volume":"77","author":"Hatemi G","year":"2018","unstructured":"Hatemi G, Christensen R, Bang D, et al.. 2018 update of the EULAR recommendations for the management of Beh\u00e7et's syndrome. Ann Rheum Dis. 2018, 77:808-18. 10.1136\/annrheumdis-2018-213567","journal-title":"Ann Rheum Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003348","article-title":"Characteristics, treatment, and long-term outcome of gastrointestinal involvement in Beh\u00e7et's syndrome: a STROBE-compliant observational study from a dedicated multidisciplinary center","volume":"95","author":"Hatemi I","year":"2016","unstructured":"Hatemi I, Esatoglu SN, Hatemi G, Erzin Y, Yazici H, Celik AF. Characteristics, treatment, and long-term outcome of gastrointestinal involvement in Beh\u00e7et's syndrome: a STROBE-compliant observational study from a dedicated multidisciplinary center. Medicine (Baltimore). 2016, 95:e3348. 10.1097\/MD.0000000000003348","journal-title":"Medicine (Baltimore)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.08.042","article-title":"Adalimumab for the treatment of Japanese patients with intestinal Beh\u00e7et's disease","volume":"13","author":"Tanida S","year":"2015","unstructured":"Tanida S, Inoue N, Kobayashi K, et al.. Adalimumab for the treatment of Japanese patients with intestinal Beh\u00e7et's disease. Clin Gastroenterol Hepatol. 2015, 13:940-8. 10.1016\/j.cgh.2014.08.042","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000520696","article-title":"Beh\u00e7et\u2019s disease: an in-depth review about pathogenesis, gastrointestinal manifestations, and management","volume":"6","author":"Nguyen A","year":"2021","unstructured":"Nguyen A, Upadhyay S, Javaid MA, et al.. Beh\u00e7et\u2019s disease: an in-depth review about pathogenesis, gastrointestinal manifestations, and management. Inflamm Intest Dis. 2021, 6:175-85. 10.1159\/000520696","journal-title":"Inflamm Intest Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.3331","article-title":"OP0152 comparison of diagnostic criteria in Beh\u00e7et disease and sensitivity in diagnosing severe manifestations","volume":"80","author":"\u00c1lvarez-Reguera C","year":"2021","unstructured":"\u00c1lvarez-Reguera C, Herrero-Morant A, Sanchez-Bilbao L, et al.. OP0152 comparison of diagnostic criteria in Beh\u00e7et disease and sensitivity in diagnosing severe manifestations. Ann Rheum Dis. 2021, 80:91-2. 10.1136\/annrheumdis-2021-eular.3331","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i13.3801","article-title":"Gastrointestinal Beh\u00e7et's disease: a review","volume":"21","author":"Skef W","year":"2015","unstructured":"Skef W, Hamilton MJ, Arayssi T. Gastrointestinal Beh\u00e7et's disease: a review. World J Gastroenterol. 2015, 21:3801-12. 10.3748\/wjg.v21.i13.3801","journal-title":"World J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4078\/jrd.2021.28.1.4","article-title":"Advances in management of intestinal Beh\u00e7et\u2019s disease: a perspective from gastroenterologists","volume":"28","author":"Cheon JH","year":"2021","unstructured":"Cheon JH. Advances in management of intestinal Beh\u00e7et\u2019s disease: a perspective from gastroenterologists. J Rheum Dis. 2021, 28:4-16. 10.4078\/jrd.2021.28.1.4","journal-title":"J Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljae263","article-title":"British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Beh\u00e7ets 2024","volume":"191","author":"Murphy R","year":"2024","unstructured":"Murphy R, Moots RJ, Brogan P, et al.. British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Beh\u00e7ets 2024. Br J Dermatol. 2024, 191:e8-e25. 10.1093\/bjd\/ljae263","journal-title":"Br J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/360826-successful-treatment-of-refractory-mucocutaneous-behets-disease-with-gastrointestinal-involvement-using-anti-tumor-necrosis-factor-alpha-anti-tnf--therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T06:26:22Z","timestamp":1748413582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/360826-successful-treatment-of-refractory-mucocutaneous-behets-disease-with-gastrointestinal-involvement-using-anti-tumor-necrosis-factor-alpha-anti-tnf--therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.84937","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,27]]}}}